List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 1521 studies with search of:   United States, Nevada
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
2 Active, not recruiting Phase 3 Trial of CP-675,206 Versus Either Dacarbazine or Temozolomide in Patients Without Prior Therapy
Condition: Melanoma
Interventions: Drug: dacarbazine or temozolomide (choice);   Drug: CP-675,206
3 Recruiting A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Sunitinib;   Drug: paclitaxel;   Drug: bevacizumab;   Drug: paclitaxel
4 Recruiting Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Conditions: Dyslipidemias;   Carotid Artery Disease;   Coronary Heart Disease
Interventions: Drug: ABT-335;   Drug: Placebo
5 Completed Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery
Conditions: Pain;   Hallux Valgus
Interventions: Drug: valdecoxib;   Drug: valdecoxib;   Drug: valdecoxib/placebo
6 Recruiting Lamotrigine Extended-Release In Elderly Patients With Epilepsy
Condition: Epilepsy
Intervention: Drug: Lamotrigine
7 Recruiting Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)
Condition: Carcinoma, Renal Cell
Interventions: Drug: Sunitinib Malate Continuous Daily Dosing;   Drug: Sunitinib Malate Schedule 4/2
8 Completed Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: GSK189075
9 Recruiting Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: SU011248;   Drug: Chemotherapy
10 Completed Study In People With Type 2 Diabetes
Condition: Non-Insulin-Dependent Diabetes Mellitus
Interventions: Drug: Pioglitazone;   Drug: GW677954
11 Recruiting Axitinib (Ag 013736) As Second Line Therapy For Metastatic Renal Cell Cancer
Condition: Kidney Neoplasms
Interventions: Drug: Axitinib (AG-013736);   Drug: Sorafenib
12 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
13 Completed COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: GW406381
14 Completed Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Conditions: Bowel Dysfunction;   Constipation
Intervention: Drug: alvimopan
15 Completed Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Conditions: Bowel Dysfunction;   Constipation
Intervention: Drug: alvimopan
16 Recruiting Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: sunitinib + mFOLFOX6;   Drug: bevacizumab + mFOLFOX6
17 Completed Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: rosiglitazone
18 Terminated GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Tesaglitazar (0.5 or 1 mg);   Drug: Pioglitazone (15, 30 or 45 mg)
19 Completed Double-Blind, Randomized Study Of The Analgesic Efficacy And Safety Of Valdecoxib 20 Mg Daily And Valdecoxib 20 Mg Twice Daily Compared To Placebo For Management Of Acute Postsurgical Pain In Anterior Cruciate Ligament (ACL) Reconstruction
Condition: Pain
Interventions: Drug: placebo;   Drug: valdecoxib;   Drug: valdecoxib
20 Active, not recruiting Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza
Condition: Pain
Intervention: Drug: morphine sulfate extended release capsules

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services